Ovid Therapeutics Inc.
US ˙ NasdaqCM ˙ US6904691010

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Kevin Joseph Fitzgerald. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Kevin Joseph Fitzgerald reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:OVID / Ovid Therapeutics Inc. Director 17,578
US:ALNY / Alnylam Pharmaceuticals, Inc. CSO & EVP, Head of Research 20,569
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Kevin Joseph Fitzgerald. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas OVID / Ovid Therapeutics Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em OVID / Ovid Therapeutics Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

OVID / Ovid Therapeutics Inc. Insider Trades
Vendas Internas OVID / Ovid Therapeutics Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em OVID / Ovid Therapeutics Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

OVID / Ovid Therapeutics Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Kevin Joseph Fitzgerald conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-04-09 2026-04-07 4 OVID Ovid Therapeutics Inc.
Common Stock
A - Award 17,578 17,578 2.56 45,000 45,000
2026-03-06 2026-03-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -153 20,569 -0.74 326.24 -49,915 6,710,431
2026-03-06 2026-03-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -148 20,722 -0.71 324.60 -48,041 6,726,361
2026-03-06 2026-03-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -233 20,870 -1.10 323.25 -75,317 6,746,228
2026-03-06 2026-03-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -124 21,103 -0.58 321.81 -39,904 6,791,156
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -57 21,227 -0.27 325.67 -18,563 6,912,997
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -75 21,284 -0.35 324.88 -24,366 6,914,746
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -210 21,359 -0.97 323.84 -68,006 6,916,899
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -96 21,569 -0.44 323.01 -31,009 6,967,003
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -79 21,665 -0.36 321.82 -25,424 6,972,230
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -59 21,744 -0.27 320.81 -18,928 6,975,693
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -28 21,803 -0.13 320.01 -8,960 6,977,178
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -29 21,831 -0.13 319.03 -9,252 6,964,744
2026-03-04 2026-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -359 21,860 -1.62 321.58 -115,447 7,029,739
2026-03-04 2026-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -722 22,219 -3.15 320.51 -231,408 7,121,412
2026-03-04 2026-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -282 22,941 -1.21 318.62 -89,851 7,309,461
2026-03-04 2026-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -289 23,223 -1.23 316.55 -91,483 7,351,241
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -37 23,512 -0.16 332.64 -12,308 7,821,032
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -94 23,549 -0.40 331.93 -31,201 7,816,620
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -81 23,643 -0.34 330.85 -26,799 7,822,287
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -170 23,724 -0.71 329.71 -56,051 7,822,040
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -100 23,894 -0.42 328.71 -32,871 7,854,197
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -329 23,994 -1.35 327.67 -107,803 7,862,114
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -392 24,323 -1.59 326.81 -128,110 7,949,000
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -258 24,715 -1.03 325.63 -84,013 8,047,945
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -90 24,973 -0.36 324.65 -29,218 8,107,484
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -47 25,063 -0.19 323.62 -15,210 8,110,888
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3,688 25,110 17.22
2026-02-25 2026-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 158 21,422 0.74
2026-02-17 2026-02-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,041 21,264 -8.76 331.96 -677,532 7,058,810
2026-02-17 2026-02-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,959 23,305 -7.75 310.08 -607,448 7,226,433
2026-02-17 2026-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 4,000 25,264 18.81
2026-01-14 2026-01-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -122 21,264 -0.57 374.33 -45,668 7,959,753
2026-01-14 2026-01-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -280 21,386 -1.29 372.93 -104,420 7,975,481
2026-01-14 2026-01-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -485 21,666 -2.19 371.24 -180,051 8,043,286
2026-01-14 2026-01-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -644 22,151 -2.83 370.00 -238,280 8,195,870
2026-01-14 2026-01-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -562 22,795 -2.41 368.76 -207,243 8,405,884
2026-01-14 2026-01-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -197 23,357 -0.84 367.52 -72,401 8,584,165
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -15 23,554 -0.06 377.82 -5,667 8,899,172
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -19 23,569 -0.08 375.65 -7,137 8,853,695
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -14 23,588 -0.06 374.44 -5,242 8,832,291
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -2 23,602 -0.01 372.46 -745 8,790,801
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -19 23,604 -0.08 370.87 -7,047 8,754,015
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -40 23,623 -0.17 369.48 -14,779 8,728,226
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -92 23,663 -0.39 368.62 -33,913 8,722,655
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -41 23,755 -0.17 367.40 -15,063 8,727,587
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -50 23,796 -0.21 366.41 -18,320 8,719,092
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -220 23,846 -0.91 365.56 -80,423 8,717,144
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -199 24,066 -0.82 364.83 -72,601 8,779,999
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -47 24,265 -0.19 363.55 -17,087 8,821,541
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -73 24,312 -0.30 362.38 -26,454 8,810,183
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -98 24,385 -0.40 361.45 -35,422 8,813,958
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -155 24,483 -0.63 360.22 -55,834 8,819,266
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -85 24,638 -0.34 359.14 -30,527 8,848,491
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -123 24,723 -0.50 358.18 -44,056 8,855,284
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -96 24,846 -0.38 357.17 -34,288 8,874,246
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -41 24,942 -0.16 356.09 -14,600 8,881,597
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -42 24,983 -0.17 355.16 -14,917 8,872,962
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -39 25,025 -0.16 353.95 -13,804 8,857,599
2026-01-14 2026-01-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3,800 25,064 17.87
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -295 21,264 -1.37 463.08 -136,609 9,846,933
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -323 21,559 -1.48 461.96 -149,213 9,959,396
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -707 21,882 -3.13 460.84 -325,814 10,084,101
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -622 22,589 -2.68 459.89 -286,052 10,388,455
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -794 23,211 -3.31 458.41 -363,978 10,640,155
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -262 24,005 -1.08 457.39 -119,836 10,979,647
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -364 24,267 -1.48 456.25 -166,075 11,071,819
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -368 24,631 -1.47 455.24 -167,528 11,213,016
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -129 24,999 -0.51 451.51 -58,245 11,287,298
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -96 25,128 -0.38 450.09 -43,209 11,309,862
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,168 25,224 -24.46 449.00 -3,667,432 11,325,576
2025-11-19 2025-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 8,161 33,392 32.35 119.13 972,220 3,977,989
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -3 25,231 -0.01 457.64 -1,373 11,546,715
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -122 25,234 -0.48 457.43 -55,806 11,542,789
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -60 25,356 -0.24 455.82 -27,349 11,557,772
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -203 25,416 -0.79 454.84 -92,333 11,560,213
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -273 25,619 -1.05 453.77 -123,879 11,625,134
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -555 25,892 -2.10 452.69 -251,243 11,721,049
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -276 26,447 -1.03 451.86 -124,713 11,950,341
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -449 26,723 -1.65 450.81 -202,414 12,046,996
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -207 27,172 -0.76 449.79 -93,107 12,221,694
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -150 27,379 -0.54 448.77 -67,316 12,286,874
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -47 27,529 -0.17 447.92 -21,052 12,330,790
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -96 27,576 -0.35 446.53 -42,867 12,313,511
2025-10-03 2025-10-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 2,851 27,672 11.49
2025-10-03 2025-10-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 2,102 24,821 9.25
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -12 22,719 -0.05 455.82 -5,470 10,355,775
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -241 22,731 -1.05 454.84 -109,616 10,338,968
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -543 22,972 -2.31 454.04 -246,544 10,430,207
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -329 23,515 -1.38 452.96 -149,024 10,651,354
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -103 23,844 -0.43 451.99 -46,555 10,777,250
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -39 23,947 -0.16 450.92 -17,586 10,798,181
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -90 23,986 -0.37 449.92 -40,493 10,791,781
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -39 24,076 -0.16 447.98 -17,471 10,785,566
2025-08-19 2025-08-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 2,851 24,115 13.41
2025-07-02 2025-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 7,763 21,264 57.50
2025-03-05 2025-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -71 13,501 -0.52 242.93 -17,248 3,279,798
2025-03-05 2025-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -324 13,572 -2.33 241.68 -78,304 3,280,081
2025-03-05 2025-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -328 13,896 -2.31 240.95 -79,032 3,348,241
2025-03-05 2025-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -121 14,224 -0.84 239.24 -28,948 3,402,950
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -219 14,345 -1.50 245.30 -53,721 3,518,828
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -487 14,564 -3.24 243.94 -118,799 3,552,742
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -465 15,051 -3.00 242.69 -112,851 3,652,727
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1 15,516 -0.01 248.36 -248 3,853,554
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -4 15,517 -0.03 247.35 -989 3,838,130
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -45 15,521 -0.29 246.18 -11,078 3,820,960
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -111 15,566 -0.71 245.26 -27,224 3,817,717
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -151 15,677 -0.95 244.41 -36,906 3,831,616
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -224 15,828 -1.40 243.36 -54,513 3,851,902
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -204 16,052 -1.25 242.37 -49,443 3,890,523
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3,871 16,256 31.26
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -37 12,385 -0.30 244.11 -9,032 3,023,302
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -75 12,422 -0.60 243.23 -18,242 3,021,403
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -187 12,497 -1.47 242.44 -45,336 3,029,773
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -79 12,684 -0.62 241.51 -19,079 3,063,313
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -48 12,763 -0.37 240.32 -11,535 3,067,204
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -22 12,811 -0.17 239.18 -5,262 3,064,135
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -21 12,833 -0.16 238.33 -5,005 3,058,489
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -27 12,854 -0.21 236.51 -6,386 3,040,100
2025-02-18 2025-02-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -83 12,881 -0.64 259.10 -21,505 3,337,467
2025-02-18 2025-02-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -76 12,964 -0.58 257.79 -19,592 3,341,990
2025-02-18 2025-02-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -80 13,040 -0.61 256.05 -20,484 3,338,892
2025-02-18 2025-02-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -115 13,120 -0.87 251.60 -28,934 3,300,992
2025-02-18 2025-02-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,086 13,235 -7.58 250.21 -271,728 3,311,529
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -14 14,321 -0.10 264.87 -3,708 3,793,203
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -12 14,335 -0.08 263.33 -3,160 3,774,836
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -26 14,347 -0.18 261.45 -6,798 3,751,023
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -21 14,373 -0.15 260.57 -5,472 3,745,173
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -12 14,394 -0.08 259.72 -3,117 3,738,410
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -33 14,406 -0.23 258.07 -8,516 3,717,756
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -26 14,439 -0.18 257.51 -6,695 3,718,187
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -53 14,465 -0.37 256.29 -13,583 3,707,235
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -47 14,518 -0.32 255.56 -12,011 3,710,220
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -110 14,565 -0.75 254.35 -27,978 3,704,608
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -164 14,675 -1.11 253.37 -41,553 3,718,205
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -145 14,839 -0.97 252.50 -36,612 3,746,848
2025-02-18 2025-02-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 2,103 14,984 16.33
2024-11-27 2024-11-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -110 12,881 -0.85 254.48 -27,993 3,277,957
2024-11-27 2024-11-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -360 12,991 -2.70 253.44 -91,238 3,292,439
2024-11-27 2024-11-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -851 13,351 -5.99 251.98 -214,435 3,364,185
2024-11-27 2024-11-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -210 14,202 -1.46 250.45 -52,594 3,556,891
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -84 14,412 -0.58 252.27 -21,191 3,635,715
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -826 14,496 -5.39 251.42 -207,673 3,644,584
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -318 15,322 -2.03 250.68 -79,716 3,840,919
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -215 15,640 -1.36 249.60 -53,664 3,903,744
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -26 15,855 -0.16 247.77 -6,442 3,928,393
2024-11-27 2024-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3,000 15,881 23.29
2024-08-14 2024-08-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -135 12,881 -1.04 274.65 -37,078 3,537,767
2024-08-14 2024-08-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,158 13,016 -8.17 273.73 -316,979 3,562,870
2024-08-14 2024-08-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,913 14,174 -21.63 272.43 -1,066,019 3,861,423
2024-08-14 2024-08-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,736 18,087 -24.08 271.32 -1,556,292 4,907,365
2024-08-14 2024-08-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9,662 23,823 -28.85 270.17 -2,610,383 6,436,260
2024-08-14 2024-08-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,421 33,485 -4.07 268.66 -381,766 8,996,080
2024-08-14 2024-08-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 14,058 34,906 67.43 85.00 1,194,930 2,967,010
2024-08-14 2024-08-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,667 20,848 47.01 97.72 651,499 2,037,267
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -125 14,181 -0.87 235.19 -29,399 3,335,229
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -138 14,306 -0.96 234.66 -32,383 3,357,046
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -86 14,444 -0.59 233.53 -20,084 3,373,107
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -161 14,530 -1.10 232.54 -37,439 3,378,806
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -74 14,691 -0.50 231.59 -17,138 3,402,289
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -227 14,765 -1.51 229.93 -52,194 3,394,916
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -198 14,992 -1.30 229.06 -45,354 3,434,068
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -96 15,190 -0.63 228.30 -21,917 3,467,877
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -26 15,286 -0.17 226.82 -5,897 3,467,171
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -13 15,312 -0.08 225.55 -2,932 3,453,622
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -9 15,325 -0.06 224.17 -2,018 3,435,405
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -45 15,334 -0.29 221.71 -9,977 3,399,701
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 2,498 15,379 19.39
2024-03-28 3 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
12,881
2024-03-28 3 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
537
2022-02-04 2022-02-03 4 OVID Ovid Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2021-10-07 2021-10-06 4 OVID Ovid Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 30,000 30,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)